logo
Select company
Select metric
1.25Cash Ratio
VS
Market
72
Sector
49
Industry
35
History
9
$ 34.63Close
$ 12.38 - $ 35.37 52-Week Range
Ticker Information

Ticker

ANAB

Company Name

ANAPTYSBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ANAPTYSBIO INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ANAB - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 44.3M1.25$ 35.53M
3/31/2025$ 98.64M2.24$ 44.04M
12/31/2024$ 123.08M2.71$ 45.43M
9/30/2024$ 191.58M4.37$ 43.88M
6/30/2024$ 71.82M1.78$ 40.42M
3/31/2024$ 53.7M1.66$ 32.3M
12/31/2023$ 35.97M0.96$ 37.44M
9/30/2023$ 26.3M0.67$ 39.18M
6/30/2023$ 35.21M0.85$ 41.63M
3/31/2023$ 94.56M2.64$ 35.8M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ANAPTYSBIO INC's latest trailing twelve months (TTM) Cash Ratio stands at 8.55.
  • Over the past 5 years, ANAPTYSBIO INC's average Cash Ratio has been 7.02.
  • The median Cash Ratio for ANAPTYSBIO INC during this period was 2.76
  • ANAPTYSBIO INC reached its highest Cash Ratio over the past 5 years at 30.79.
  • The lowest Cash Ratio recorded by ANAPTYSBIO INC in the same timeframe 0.67

ANAPTYSBIO INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
PHAT : PHATHOM PHARMACEUTICALS INC 1.66NAGE : NIAGEN BIOSCIENCE INC 2.71GYRE : GYRE THERAPEUTICS INC 2.16CRMD : CORMEDIX INC 5.02XNCR : XENCOR INC 0.47TBPH : THERAVANCE BIOPHARMA INC 5.18ZYME : ZYMEWORKS INC 2.55KURA : KURA ONCOLOGY INC 0.76ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC 5.41ZVRA : ZEVRA THERAPEUTICS INC 1.65

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ANAPTYSBIO INC is calculated as follows: CashnEq [ $ 209.21M ] / LiabilitesC [ $ 24.47M ]
(=) Cash Ratio [ 8.55 ]

ANAB - Cash Ratio, Last 5 years

0.67

Minimum

Sep 30, 2023

30.79

Maximum

Dec 31, 2021

7.02

Average

2.76

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63